EXCHANGE TRADED CONCEPTS, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1457320
OKLAHOMA CITY, OK
Position in PTGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,957,119
+$451,445 QoQ
Shares Held
24,124
+1.5% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#126
of 341 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EXCHANGE TRADED CONCEPTS, LLC holds $67,738,617 across 34 Biotechnology names. PTGX ranks #10 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
276,954 | $9,801,401 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,357 | $7,628,281 | |
| 3 | INVA |
Innoviva, Inc.
|
164,758 | $3,741,654 | |
| 4 | MANE |
Veradermics, Inc
|
30,168 | $3,708,853 | |
| 5 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
358,783 | $3,555,539 | |
| 6 | KLRA |
Kailera Therapeutics, Inc.
|
152,501 | $3,359,597 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
87,891 | $3,200,111 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
81,186 | $3,167,065 |
All Filings in PTGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,957,119 | 24,124 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $2,505,674 | 23,773 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $3,060,306 | 35,039 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $2,228,859 | 33,552 | Shares | Other | 2025-10-14 | |
| 2025-06-30 | $2,619,300 | 47,391 | Shares | Other | 2025-07-10 | |
| 2025-03-31 | $1,324,677 | 27,392 | Shares | Other | 2025-04-17 | |
| 2024-12-31 | $39,565 | 1,025 | Shares | Other | 2025-01-21 | |
| 2024-09-30 | $43,245 | 961 | Shares | Other | 2024-10-10 | |
| No filing history on record for this holder in this stock. | ||||||